Business Context and Reporting Period
Company: Chemed Corporation (CHEMED CORP)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Segments: The Company operates in two primary segments: Vitas Group (hospice care services) and Roto-Rooter Group (sewer, drain, and pipe cleaning, and plumbing repair).
Employees: 11,783 as of December 31, 2007.
Key Financial Metrics
Note: Specific revenue, net income, and cash flow totals for the fiscal year are incorporated by reference from the 2007 Annual Report to Stockholders and are not explicitly stated in the provided text. The following metrics are available from the filing text:
- Debt: The Company increased outstanding debt by $74.3 million in 2007. As of December 31, 2007, variable rate debt outstanding was $24.5 million.
- Debt Valuation: The market value of long-term debt was approximately $210.5 million versus a carrying value of $224.8 million.
- Interest Rate Risk: For every $10 million of variable rate debt, a 100 basis point change in interest rates alters annual interest expense by $100,000.
- Revenue Composition (Vitas): Over 90% of Vitas's net patient service revenue is derived from Medicare and Medicaid programs. Medicaid accounted for 5% of Vitas revenues in 2007.
- Equity: 24,149,296 shares of Capital Stock were outstanding as of February 15, 2008. Aggregate market value of voting stock held by non-affiliates was $1,549,430,319 (as of June 29, 2007).
- Dividends: Quarterly dividends paid were $0.06 per share throughout 2007.
- Share Repurchases: The Company repurchased shares under two programs in 2007. The July 2006 program ($50M authorized) was fully utilized. The April 2007 program ($150M authorized) had $65.0 million remaining as of December 31, 2007.
Material Changes and Unusual Items
- Debt Increase: Outstanding debt increased by $74.3 million in 2007 to finance operations.
- Seasonality (Roto-Rooter): Fourth-quarter results are disproportionately impacted by advertising costs. In Q4 2007, Roto-Rooter expensed $7.3 million in advertising, representing 32% of its full-year aggregate advertising costs.
- Legal Settlements:
- Costa Class Action: A settlement of $19.9 million was approved in June 2006 regarding wage and hour violations in California.
- Patient Care Sale: Litigation regarding the 2002 sale of the Patient Care subsidiary settled in October 2006. The Company recorded a pretax impairment charge of $1.4 million related to a warrant. In December 2007, note terms were amended, and the buyer paid $5 million of principal on December 31, 2007, with an additional $5.7 million paid in early 2008.
- Environmental Liability: Accrual for potential environmental cleanup costs related to the former DuBois Chemicals Inc. was $1.7 million as of December 31, 2007. The Company is contingently liable for up to $14.9 million more, though management does not believe payment is probable.
Guidance, Outlook, Risks, and Contingencies
Management Commentary & Outlook: The Company's success depends on managing costs within the per diem reimbursement structure of Medicare/Medicaid for Vitas and maintaining competitive advantages in the fragmented Roto-Rooter market. Management believes disclosure controls and procedures are effective.
Key Risks:
- Regulatory & Reimbursement (Vitas): Over 90% of Vitas revenue relies on government payments. Risks include changes in Medicare/Medicaid rates, eligibility rules (e.g., the six-month life expectancy certification), and payment caps. Increased scrutiny of claims and audits could lead to recoupments.
- Legal & Compliance: Ongoing OIG investigation regarding billing practices (subpoenas served in 2005). Risks associated with Anti-Kickback laws, Stark Law, and False Claims Act. A new class action lawsuit (Santos) was filed in September 2006 regarding California wage and hour issues; liability is currently unestimable.
- Debt & Liquidity: High leverage limits flexibility. Debt covenants restrict dividends, additional borrowing, and asset sales. Variable interest rates expose the Company to rising interest costs.
- Competition: Roto-Rooter faces intense competition from local/regional firms. Vitas competes with non-profits and national providers; barriers to entry are low.
- Workforce: A nationwide shortage of qualified nurses could increase labor costs and impact Vitas's ability to provide care.
Investor Verification Checklist
- Verify the specific total revenue, net income, and operating cash flow figures for 2007 in the full 2007 Annual Report to Stockholders (incorporated by reference).
- Monitor the status of the OIG investigation and the pending Santos class action lawsuit for potential financial impact.
- Review upcoming Medicare/Medicaid reimbursement rate adjustments and their impact on Vitas margins.
- Assess the Company's ability to service its increased debt load ($74.3M increase in 2007) given variable interest rate exposure.
- Confirm the status of the $14.9 million contingent environmental liability related to DuBois Chemicals.